Drug Shortage Report for ONCASPAR

Last updated on 2025-03-20 History
Report ID 241135
Drug Identification Number 02461900
Brand name ONCASPAR
Common or Proper name Pegaspargase injection
Company Name SERVIER CANADA INC
Market Status MARKETED
Active Ingredient(s) PEGASPARGASE
Strength(s) 750UNIT
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 5 ml
ATC code L01XX
ATC description
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2025-03-19
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2025-03-20
Company comments US-Labelled PrONCASPAR® (pegaspargase injection) is available.
Health Canada comments
Tier 3 Status Yes
Contact Address 3224 AVENUE JEAN-BÉRAUD
LAVAL, QUEBEC
CANADA H7T 2S4
Company contact information Address: 3224, rue Jean-Béraud, bur. 270, Laval, Quebec, H7T 2S4 Phone : (450) 978-9700

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v24 2025-03-20 English Compare
v23 2025-03-19 French Compare
v22 2025-03-19 English Compare
v21 2025-03-15 English Compare
v20 2025-03-13 French Compare
v19 2025-03-13 English Compare
v18 2025-03-11 French Compare
v17 2025-03-11 English Compare
v16 2025-03-08 English Compare
v15 2025-02-28 French Compare
v14 2025-02-28 English Compare
v13 2025-02-13 French Compare
v12 2025-02-13 English Compare
v11 2025-01-16 French Compare
v10 2025-01-16 English Compare
v9 2024-12-13 French Compare
v8 2024-12-13 English Compare
v7 2024-12-02 English Compare
v6 2024-11-28 French Compare
v5 2024-11-28 English Compare

Showing 1 to 20 of 24